Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond

Journal of Radiation Research

Volumn 54, Issue SUPPL.1, 2013, Pages

  Combs, Stephanie E ^a   Djosanjh, Manjit ^b   Pötter, Richad ^c   Orrechia, Roberto ^d   Haberer, Thomas ^a   Durante, Marco ^e   Fossati, Piero ^f   Parodi, Katia ^g   Balosso, Jacques ^h   Amaldi, Ugo ^b   Baumann, Michael ⁱ   Debus, Jürgen ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b CERN   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

^f Centro Nazionale Adroterapia Oncologica CNAO   (Italy)

^g UNIVERSITY OF MUNICH   (Germany)

^h GCS ETOILE   (France)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARTICLE THERAPY;

EID: 84880243910     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt039     Document Type: Article

References (44)

1. Wilson RR. Radiological use of fast protons. Radiology 1946;47:487-91.
2. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953-64.
3. Castro JR, Linstadt DE, Bahary JP et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994;29:647-55.
4. Castro JR, Saunders WM, Austin-Seymour MM et al. A phase I-II trial of heavy charged particle irradiation of malignant glioma of the brain: a Northern California Oncology Group Study. Int J Radiat Oncol Biol Phys 1985;11:1795-800.
5. Castro JR, Chen GT, Blakely EA. Current considerations in heavy charged-particle radiotherapy: a clinical research trial of the University of California Lawrence Berkeley Laboratory, Northern California Oncology Group, and Radiation Therapy Oncology Group. Radiat Res Suppl 1985;8:S263-71.
6. Castro JR. Heavy charged particle irradiation of human cancers. Radiat Med 1983;1:70-5.
7. Castro JR, Saunders WM, Quivey JM et al. Clinical problems in radiotherapy of carcinoma of the pancreas. Am J Clin Oncol 1982;5:579-87.
8. Castro JR, Quivey JM, Lyman JT et al. Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory. Cancer 1980;46:633-41.
9. Castro JR, Quivey JM, Lyman JT et al. Radiotherapy with heavy charged particles at Lawrence Berkeley Laboratory. J Can Assoc Radiol 1980;31:30-4.
10. Kaplan ID, Castro JR, Phillips TL. Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. Int J Radiat Oncol Biol Phys 1994;28:257-61.
11. Reimers M, Castro JR, Linstadt D et al. Heavy charged particle therapy of bone and soft tissue sarcoma. A phase I-II trial of the University of California Lawrence Berkeley Laboratory and the Northern California Oncology Group. Am J Clin Oncol 1986;9:488-93.
12. Saunders W, Castro JR, Chen GT et al. Helium-ion radiation therapy at the Lawrence Berkeley Laboratory: recent results of a Northern California Oncology Group Clinical Trial. Radiat Res Suppl 1985;8:S227-34.
13. Schoenthaler R, Castro JR, Halberg FE et al. Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons. Int J Radiat Oncol Biol Phys 1993;27:75-82.
14. Schoenthaler R, Castro JR, Petti PL et al. Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys 1993;26:291-8.
15. Denekamp J, Waites T, Fowler JF. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol 1997;71:681-94.
16. Ando K, Koike S, Uzawa A et al. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res 2005;46:51-7.
17. Delaney TF. Proton therapy in the clinic. Front Radiat Ther Oncol 2011;43:465-85.
18. Combs SE, Laperriere N, Brada M. Clinical controversies: proton radiation therapy for brain and skull base tumors. Semin Radiat Oncol 2013;23:120-6.
19. Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol 2010;7:37-43.
20. Tsujii H, Kamada T. A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol 2012;42:670-85.
21. Blomquist E, Bjelkengren G, Glimelius B. The potential of proton beam radiation therapy in intracranial and ocular tumours. Acta Oncol 2005;44:862-70.
22. Hocht S, Bechrakis NE, Nausner M et al. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol 2004;180:419-24.
23. Zietman AL, Bae K, Slater JD et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09. J Clin Oncol 2010;28:1106-11.
24. Zietman AL, DeSilvio ML, Slater JD et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-9.
25. Gardner BG, Zietman AL, Shipley WU et al. Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 2002;167:123-6.
26. Efstathiou JA, Trofimov AV, Zietman AL. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer. Cancer J 2009;15:312-8.
27. Zietman AL. The Titanic and the iceberg: prostate proton therapy and health care economics. J Clin Oncol 2007;25:3565-6.
28. ENLIGHT: The European Network for LIGht ion Hadron Therapy. https://enlight.web.cern.ch. 2009.
29. Dosanjh MK., Hoffmann HF, Magrin G. Status of hadron therapy in Europe and the role of ENLIGHT. Nucl Instrum Methods Phys Res 2007;A571:191-4.
30. Dosanjh M, Jones B, Mayer R. ENLIGHT and other EU-funded projects in hadron therapy. Br J Radiol 2010;83:811-3.
31. Dosanjh M, Cirilli M, Greco V et al. ENLIGHT: the European Network for light ion hadron therapy. Health Phys 2012;103-5:674-80.
32. Kessel KA, Bougatf N, Bohn C et al. Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework. Radiat Oncol 2012;7:115.
33. Kessel KA, Habermehl D, Bohn C et al. Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer. Strahlenther Onkol 2012;188:1119-24.
34. Blattmann C, Oertel S, Schulz-Ertner D et al. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer 2010;10:96.
35. Combs SE, Kieser M, Habermehl D et al. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer 2012;12:137.
36. Combs SE, Kieser M, Rieken S et al. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial. BMC Cancer 2010;10:478.
37. Combs SE, Habermehl D, Ganten T et al. Phase I study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial. BMC Cancer 2011;11:67.
38. Combs SE, Edler L, Burkholder I et al. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial. BMC Cancer 2010;10:615.
39. Combs SE, Burkholder I, Edler L et al. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial. BMC Cancer 2010;10:533.
40. Nikoghosyan AV, Karapanagiotou-Schenkel I, Munter MW et al. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study. BMC Cancer 2010;10:607.
41. Nikoghosyan AV, Rauch G, Munter MW et al. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study. BMC Cancer 2010;10:606.
42. Jensen AD, Nikoghosyan A, Hinke A et al. Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy]. BMC Cancer 2011;11:70.
43. Jensen AD, Nikoghosyan A, Windemuth-Kieselbach C et al. Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC. BMC Cancer 2010;10:546.
44. Jensen AD, Krauss J, Potthoff K et al. Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx-TPF-C-HIT. BMC Cancer 2011;11:182.